ArticlePloS one2014
CCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistance.
Tian Gao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
82 papers cite itlatest 60 shown
this papertrialcites it
ArticlePloS one2014
Tian Gao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.